Myeloma New Zealand - Latest News [Page 1]

Cancer Agency Report Duplicates Pharmac Role

Thursday, 28 April 2022, 5:01 pm | Myeloma New Zealand

The Cancer Control Agency’s analysis of the gap between Australia and New Zealand in funding 18 selected medicines with substantial clinical benefit is a welcome way of drawing attention to the plight of NZ cancer patients desperate for treatments ... More >>

Patient advocacy group presents to Health Select Committee

Wednesday, 7 August 2019, 9:35 am | Myeloma New Zealand

Dr Ken Romeril, chief executive, Myeloma New Zealand, is appearing today before the Health Select Committee in support of their submission asking for funding of six life-extending treatments for multiple myeloma patients. More >>

New Zealand falling behind rest of world in cancer treatment

Wednesday, 26 June 2019, 10:00 am | Myeloma New Zealand

The management of New Zealand’s most common blood cancer, myeloma, is falling behind the rest of the world, putting lives at unnecessary risk of this incurable but treatable disease. More >>

Blood cancer patients advocate pleads for treatment funding

Wednesday, 8 May 2019, 9:26 am | Myeloma New Zealand

Patient advocacy group Myeloma New Zealand has joined forces with other patient groups to petition Parliament to approve funding for state-of-the-art cancer treatments for New Zealanders. Myeloma NZ is petitioning for funding for a suite of six life-extending ... More >>

Lack of effective treatments for blood cancer patients

Thursday, 12 April 2018, 1:15 pm | Myeloma New Zealand

Lack of access to effective treatments is forcing blood cancer patients to take desperate measures More >>